CombiMatrix Corp. (CBMX) Starts Presentation at LD Micro Conference

CombiMatrix  provides molecular diagnostic solutions and comprehensive clinical support designed to foster the highest quality in patient care. CombiMatrix specializes in pre-implantation genetic screening (PGS), prenatal diagnosis, miscarriage analysis, and pediatric genetics, offering DNA-based testing for the detection of genetic abnormalities beyond what can be identified through traditional methodologies. The company performs genetic testing utilizing a variety of advanced cytogenomic techniques, including chromosomal microarray, standardized and customized fluorescence in situ hybridization (“FISH”) and high-resolution karyotyping. For more information, visit the company’s website at www.combimatrix.com